ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Return
7.83%
This Quarter Return
+4.69%
1 Year Return
-7.83%
3 Year Return
+43.87%
5 Year Return
+57.06%
10 Year Return
–
AUM
$307M
AUM Growth
-$24.1M
(-7.3%)
Cap. Flow
-$41.9M
Cap. Flow
% of AUM
-13.66%
Top 10 Holdings %
Top 10 Hldgs %
29.87%
Holding
756
New
86
Increased
147
Reduced
194
Closed
27
Top Buys
| 1 |
Energy Select Sector SPDR Fund
XLE
|
+$12.7M |
| 2 |
iShares MSCI Turkey ETF
TUR
|
+$10.6M |
| 3 |
Stellantis
STLA
|
+$7.3M |
| 4 |
Merck
MRK
|
+$1.7M |
| 5 |
Qiagen
QGEN
|
+$1.7M |
Top Sells
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$8.3M |
| 2 |
Linde
LIN
|
+$6.99M |
| 3 |
Alibaba
BABA
|
+$5.81M |
| 4 |
iShares MSCI South Korea ETF
EWY
|
+$5.61M |
| 5 |
UBS Group
UBS
|
+$3.63M |
Sector Composition
| 1 | Technology | 14.93% |
| 2 | Healthcare | 13.84% |
| 3 | Financials | 9.97% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Communication Services | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Cidara Therapeutics
CDTX
$1.58B
| $102K | 0.03% |
1,793
-118
| -6% | -$6.73K |
|
277
Xcel Energy
XEL
$42.4B
| $102K | 0.03% |
1,477
+250
| +20% | +$17.3K |
|
|
CGC
278
Canopy Growth
CGC
$421M
| $102K | 0.03% |
711
| – | – |
|
279
MetLife
MET
$52.9B
| $101K | 0.03% |
2,728
-439
| -14% | -$16.3K |
|
280
Boeing
BA
$175B
| $101K | 0.03% |
+611
| New | +$101K |
|
281
Phreesia
PHR
$1.6B
| $98.6K | 0.03% |
+3,069
| New | +$98.6K |
|
|
CCXI
282
DELISTED
ChemoCentryx, Inc.
CCXI
| $98.3K | 0.03% |
1,794
+182
| +11% | +$9.97K |
|
283
Invesco KBW Bank ETF
KBWB
$4.87B
| $96.3K | 0.03% |
+2,570
| New | +$96.3K |
|
284
Phathom Pharmaceuticals
PHAT
$882M
| $96.3K | 0.03% |
2,627
-150
| -5% | -$5.5K |
|
|
RCS
285
PIMCO Strategic Income Fund
RCS
$343M
| $96.3K | 0.03% |
15,001
-8,000
| -35% | -$51.4K |
|
286
Tractor Supply
TSCO
$31.8B
| $95.9K | 0.03% |
3,345
+3,315
| +11,050% | +$95K |
|
287
Rapid7
RPD
$1.33B
| $94.2K | 0.03% |
1,539
-348
| -18% | -$21.3K |
|
|
CHNG
288
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $91.7K | 0.03% |
+6,320
| New | +$91.7K |
|
289
Nuveen Credit Strategies Income Fund
JQC
$751M
| $91.6K | 0.03% |
+15,500
| New | +$91.6K |
|
|
CNH
290
CNH Industrial
CNH
$14.4B
| $90.7K | 0.03% |
+13,390
| New | +$90.7K |
|
291
ProShares Ultra S&P500
SSO
$7.24B
| $90.4K | 0.03% |
+2,460
| New | +$90.4K |
|
292
Sarepta Therapeutics
SRPT
$1.84B
| $89.3K | 0.03% |
636
| – | – |
|
293
Teva Pharmaceuticals
TEVA
$22.1B
| $88.8K | 0.03% |
9,861
+4,606
| +88% | +$41.5K |
|
294
Axsome Therapeutics
AXSM
$6.45B
| $88.6K | 0.03% |
1,243
-57
| -4% | -$4.06K |
|
|
AQUA
295
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $88.3K | 0.03% |
+4,160
| New | +$88.3K |
|
296
CVS Health
CVS
$89.1B
| $87.5K | 0.03% |
1,499
-6,759
| -82% | -$395K |
|
297
Nucor
NUE
$33.1B
| $87.3K | 0.03% |
1,947
+224
| +13% | +$10K |
|
298
Merit Medical Systems
MMSI
$5.47B
| $87.3K | 0.03% |
2,008
-188
| -9% | -$8.18K |
|
|
FLIR
299
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $87.3K | 0.03% |
2,436
+2,402
| +7,065% | +$86.1K |
|
300
Haemonetics
HAE
$2.61B
| $87.2K | 0.03% |
+1,000
| New | +$87.2K |
|